GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

Jie Xiang, Liyan Qin, Jinling Zhong, Xia, Ning, Yuzhen Liang
ISSN / E-ISSN
— / —
DOI
10.2147/dmso.s425642 ↗
Volume · Issue · Pages
Volume 16 · — · 2433-2446
Publisher
Dove Medical Press Ltd.
Article URL
https://doi.org/10.2147/dmso.s425642 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Aug 2023
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Aug 2023 OpenAlex

Keywords (as given): liraglutide; semaglutide; GLP-1 receptor agonists; sarcopenic obesity; skeletal muscle atrophy; SIRT1; high-fat diet; insulin resistance; glucose tolerance; GLUT4; palmitic acid; C2C12 myotubes; EX527

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized W
Based on the recorded HEC dataset applicable to the article's publication date. Listed as W in the HEC list for 2023–24.
Journal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publication date used
01 Aug 2023 (OpenAlex publication date)
Applicable HEC period
2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
Category
W
Recognition status
Recognized (OK_RECORD_FOUND)
Source
HJRS 2023-24 page 1345, row 9447
Verification status
Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.